China Health Group Inc. (8225.HK)
Market: HKEX |
Currency: HKD
Address: Building 17
China Health Group Inc., an investment holding company, provides research and development services of drugs, bio drugs, natural drugs, and synthetic drugs in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; and post launch market research, medical, and medical market services. It also provides hospital management, clinical research and promotion, and specialized hospital services, as well as Venturepharma health cloud; and tourism recovery services. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, China.
Show more
📈 China Health Group Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
50-100%
-
Revenue Growth Range (1Y):
10-25%
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for China Health Group Inc.
No earnings history available for this symbol.
📰 Related News & Research
-
China Healthcare Outlook 2025: Growth Opportunities Amid Challenges in Biopharma, Medical Devices, and Internet Health
November 29, 2024
Comprehensive Analysis of Key Chinese Companies and Market Trends Date: Thursday, 28 November 2024 Broker: UOB Kay Hian Anta Sports: Strategic Moves Propel Growth Prospects…
-
China Healthcare Outlook 2025: Growth Opportunities Amid Challenges in Biopharma, Medical Devices, and E-commerce
November 29, 2024
In-Depth Analysis: Elite UK REIT, Anta Sports, China State Construction Engineering, Best Pacific International, and JBM Healthcare Broker Name: UOB Kay Hian Private Limited Date…
🔍 View more Reports